Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus Monotherapy in Myelodysplastic Syndromes – Pilot Study
2009-014768-21Phase 2Terminated
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in myelodysplastic syndrome (MDS), sponsored by Technische Universität Dresden. Primary endpoint: Overall hematological response rate at 4 months. Started Jan 2010; status: terminated.
02
Drugs
temsirolimus
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on 2009-014768-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014768-21.